European Medicines Agency official links AstraZeneca vaccine and thrombosis | ABS-CBN

Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
European Medicines Agency official links AstraZeneca vaccine and thrombosis
European Medicines Agency official links AstraZeneca vaccine and thrombosis
Agence France-Presse
Published Apr 06, 2021 07:45 PM PHT

ROME, Italy - A top official in the European Medicines Agency said in an interview published Tuesday that there is a link between the AstraZeneca coronavirus vaccine and blood clots.
ROME, Italy - A top official in the European Medicines Agency said in an interview published Tuesday that there is a link between the AstraZeneca coronavirus vaccine and blood clots.
"In my opinion, we can say it now, it is clear there is a link with the vaccine. But we still do not know what causes this reaction," EMA head of vaccines Marco Cavaleri told Italy's Il Messaggero newspaper.
"In my opinion, we can say it now, it is clear there is a link with the vaccine. But we still do not know what causes this reaction," EMA head of vaccines Marco Cavaleri told Italy's Il Messaggero newspaper.
He said that "in the next few hours, we will say that there is a connection, but we still have to understand how this happens."
He said that "in the next few hours, we will say that there is a connection, but we still have to understand how this happens."
Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against Covid-19 are more frequent than in the general population have undermined confidence in the beleaguered vaccine.
Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against Covid-19 are more frequent than in the general population have undermined confidence in the beleaguered vaccine.
ADVERTISEMENT
RELATED VIDEO:
After several countries suspended the use of the jab— including Italy— the EMA declared that the benefits outweigh the risks and it should remain in use.
After several countries suspended the use of the jab— including Italy— the EMA declared that the benefits outweigh the risks and it should remain in use.
But it has said that a causal link between clots and the vaccine is possible and is expected to provide an updated assessment this week.
But it has said that a causal link between clots and the vaccine is possible and is expected to provide an updated assessment this week.
"We are trying to get a precise picture of what is happening, to define in detail this syndrome due to the vaccine," Cavaleri said.
"We are trying to get a precise picture of what is happening, to define in detail this syndrome due to the vaccine," Cavaleri said.
He added: "Among the vaccinated, there are more cases of cerebral thrombosis... among young people than we would expect."
He added: "Among the vaccinated, there are more cases of cerebral thrombosis... among young people than we would expect."
Read More:
AstraZeneca
COVID-19
COVID-19 vaccine
thrombosis
blood clots
COVID-19 vaccination
European Medicines Agency
EMA
Marco Cavaleri
ANC
ADVERTISEMENT
ADVERTISEMENT